Acknowledgement
Supported by : 아벤티스 파스퇴르 코리아(주)
References
- Simoes EAF. Polioviruses. In : Behrman RE, Kliegman RM, Jensen HB, editors. Nelson Textbook of Pediatrics. 17th ed. Philadelphia : WB Saunders Co, 2004:1036-42
- Cherry JD. Enterovirus and Parechoviruses. In : Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, editors. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia : WB Saunders Co, 2004: 1984-2041
- Plotkin SA, Vidor E. Poliovirus vaccine-inactivated. In : Plotkin SA, Orestein WA, Offit PA. Vaccines. 4th ed. Philadelphia : WB Saunders Co, 2004:625-49
- Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine-live attenuated. In : Plotkin SA, Orestein WA, Offit PA. Vaccines. 4th ed. Philadelphia : Saunders, 2004:651-705
- WHO. Global eradication of poliomyelitis by the year 2000. In Forty-first World Health Assembly, Geneva, May 2-13, 1988. Geneva, WHO 1988:26
- Korea Centers for Disease Control and Prevention. Outbreak of Polio, Yemen and Indonesia, 2000. Communicable Diseases Monthly Report. Seoul, Korea Centers for Disease Control and Prevention 2005;16:110
- Sabin AB. Commentary on report on oral poliomyelitis vaccine. JAMA 1964;190:52-5 https://doi.org/10.1001/jama.1964.03070140058008
- Horstmann DM, Emons J, Gimpel L, Subrahmanyan T, Riodan JT. Enterovirus surveillance following a community- wide oral poliovirus vaccination program : A seven year study. Am J Epidemiol 1973:97;173-86 https://doi.org/10.1093/oxfordjournals.aje.a121498
- Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 1994; 11:426-38
- WHO Collaborative Study Group. The relationship between persisting spinal paralysis and poliomyelitis vaccine(oral) : results of a WHO enquiry. Bull World Health Organ 1976; 53:319-31
- WHO Collaborative Study Group. The relationship between persisting spinal paralysis and poliomyelitis vaccine : results of a ten-year enquiry. Bull World Health Organ 1982; 60:231-42
- The Committee of Infectious Diseases, Immunization Program, 5th ed, The Korean Soc of Pediar, Kwangmoon Co., Seoul, 2002:75-87
- Advisory Committee on Immunization Program, Epidemiology and preventiion of vaccine-preventable disease, Korea Center for Disease Control and Prevention, 2005: 123-37
- Albrecht P, Steenis G, Wezel L, Salk J. Standardization of poliovirus neutralizing antibody tests. Rev Inf Dis 1984:6(2 Suppl):540S-544S https://doi.org/10.1093/clinids/6.Supplement_2.S540
- Centers for Disease Control and Prevention. Progress toward global poliomyelitis eradication, 1985-1994. MMWR 1995;44:273-5
- Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992;14: 568-79 https://doi.org/10.1093/clinids/14.2.568
- Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States : Introduction of a sequential vaccination followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices. MMWR 1997;46:1-25
- McBean AM, Thoms ML, Albrecht P, Cuthie JC, Bernier R. Serologic response to oral polio vaccine and enhancedpotency inactivated polio vaccines. Am J Epidemiol 1988;128:615-28 https://doi.org/10.1093/oxfordjournals.aje.a115009
- The National Committee of Certification of Poliomyelitis Eradication in the Republic of Korea. National Documentation for Certification of Poliomyelitis Eradication, The Ministry of Health and Welfare, Seoul, 2000:2-60
- Kim JS. Evaluation of Poliomyelitis vaccination. In : Ministry of Health and Welfare, Korea. Evaluation of immunization system in Korea. Ministry of Health and Welfare, Seoul, 1995:99-113
- Kim SJ, Kim SH, Jee YM, Kim JS. Vaccine-associated paralytic poliomyelitis : A case report of flaccid monoparesis after OPV. J Korean Med Sci 2007;22 In press
- Montagnon BJ. Polio and rabies vaccines produced in continuous cell lines: A reality for Vero cell line. Dev Biol Stand 1989;70:27-47
- Robertson SE, Traverso HP, Drucker JA, Rovira EZ, Fabre-Teste B, Sow A, et al. Clinical efficacy of a new enhanced-potency, inactivated poliovirus vaccine. Lancet 1988;23;897-9 https://doi.org/10.1016/S0140-6736(00)43704-9
- Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood : systemic and local immune responses. J Infect Dis 1990;162:1291-7 https://doi.org/10.1093/infdis/162.6.1291
- Susan CA, Jones A, Faden H, Ferden MB, Kwong MS, Ogra PL. Systemic and local responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr 1992;120:686-9 https://doi.org/10.1016/S0022-3476(05)80228-8
- Halsey NA, Blatter M, Bader G. Safety and immunogenicity of a combination DPT/IPV vaccine administered to infants in a dual-chamber syringe : final report. Swiftwater, PA, Connaught Laboratories. 1994. In reference 3
- Nirmal S, Cherian T, Samuel BU, Rajasingh J, Raghupathy P, John TJ. Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine. Vaccine 1998;16:928-31 https://doi.org/10.1016/S0264-410X(97)00293-4
- Grenier B, Hamza B, Biron G, Xueref C, Viarme F, Roumiantzeff M. Seroimmunity following vaccination in infants by an inactivated poliovirus vaccine prepared on Vero cells. Rev Inf Dis 1984;6(2 Suppl):545S-547S https://doi.org/10.1093/clinids/6.Supplement_2.S545
- Ruuskanen O, Salmi TT, Stevik M, Lapinleimu K. Inactivated poliovaccine : adverse reactions and antibody responses. Acta Paediatr Scand 1980;6:397-401